ID

34418

Description

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01612286

Lien

https://clinicaltrials.gov/show/NCT01612286

Mots-clés

  1. 17/01/2019 17/01/2019 -
  2. 27/03/2020 27/03/2020 - Sarah Riepenhausen
Détendeur de droits

GSK group of companies

Téléchargé le

17 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Nasopharyngeal Carcinoma NCT01612286

Eligibility Nasopharyngeal Carcinoma NCT01612286

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
Description

ID.1

Type de données

boolean

have measurable lesions
Description

ID.2

Type de données

boolean

no dysfunction of the major organs
Description

ID.3

Type de données

boolean

can understand this study and give a signed informed consent certificates
Description

ID.4

Type de données

boolean

without a history of allergic reaction to the biological agents
Description

ID.5

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating women; women of child-bearing age without contraception
Description

ID.6

Type de données

boolean

with a serious infection or dysfunction of the major organs
Description

ID.7

Type de données

boolean

have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
Description

ID.8

Type de données

boolean

allergic to the escherichia coli preparations
Description

ID.9

Type de données

boolean

cann't understand this study and give a signed informed consent certificates
Description

ID.10

Type de données

boolean

Similar models

Eligibility Nasopharyngeal Carcinoma NCT01612286

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
diagnosed metastatic npc patient who have received radiotherapy or chemoradiotherapy with an at least 6 months interval
boolean
ID.2
Item
have measurable lesions
boolean
ID.3
Item
no dysfunction of the major organs
boolean
ID.4
Item
can understand this study and give a signed informed consent certificates
boolean
ID.5
Item
without a history of allergic reaction to the biological agents
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
pregnant or lactating women; women of child-bearing age without contraception
boolean
ID.7
Item
with a serious infection or dysfunction of the major organs
boolean
ID.8
Item
have taken other antitumor drugs during the period of 30 days ahead of this clinical trial
boolean
ID.9
Item
allergic to the escherichia coli preparations
boolean
ID.10
Item
cann't understand this study and give a signed informed consent certificates
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial